Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Rakovina Therapeutics Inc. has increased its private placement offering to $2.5 million in response to high investor demand. The funds will support the advancement of novel cancer treatments using AI platforms and the development of its kt-3000 series. The offering consists of units priced at $0.06, each including a share and a warrant.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
